Submissions

• Aggregates only. Counts and distributions, never individual stories. This removes most of the moderation burden and most of the astroturfing incentive at once.
• Minimum n = 20 per peptide-outcome pair before any aggregate publishes. Below that, a distribution is noise presented as a finding.
• Verified-purchase responses are counted separately. We ask whether you have an order number; we do not ask you to type it, so nothing identifying is held.
• Never at parity with evidence. Submissions carry the USER-REPORT tag, sit in their own section, and never appear inside the graded display. What people report and what has been measured are different kinds of claim and putting them side by side would say otherwise.
• Excluded from every score. No submission moves a grade or a transparency score.
• No free text. Every field is a fixed choice. Free text is a moderation problem that produces unusable data.

A submission reporting any adverse effect does not reach a confirmation screen. It routes to guidance on getting medical care and to the FDA’s MedWatch reporting system. We do not collect reports of harm and return a thank-you.

Where a reported effect can indicate an emergency, the response leads with getting seen now rather than with reporting. Those effects are:

• Difficulty breathing, throat tightness, or swelling of face or lips
• Chest pain, or a racing or irregular heartbeat
• Fainting, collapse, or loss of consciousness
• Severe or persistent abdominal pain
• Sudden vision changes
• Widespread rash, blistering, or peeling skin

An unrecognised effect identifier is treated as urgent rather than discarded — the two directions of error are not symmetric, and over-routing someone to care costs them a phone call.

Adverse-effect aggregates publish regardless of the n = 20 threshold. A small number of serious reports is meaningful in a way that a small number of “it worked” reports is not, and suppressing them for want of a denominator would be the wrong kind of caution.

We are not a regulator, we cannot act on a report, and we do not file with the FDA on anyone’s behalf.